vs
Side-by-side financial comparison of FIRST MID BANCSHARES, INC. (FMBH) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
FIRST MID BANCSHARES, INC. is the larger business by last-quarter revenue ($88.2M vs $57.2M, roughly 1.5× Vanda Pharmaceuticals Inc.). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs -246.8%, a 273.6% gap on every dollar of revenue. On growth, Vanda Pharmaceuticals Inc. posted the faster year-over-year revenue change (7.6% vs 3.4%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $-29.5M). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs 5.0%).
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
FMBH vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $88.2M | $57.2M |
| Net Profit | $23.7M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | 34.0% | -70.5% |
| Net Margin | 26.8% | -246.8% |
| Revenue YoY | 3.4% | 7.6% |
| Net Profit YoY | 23.5% | -2774.3% |
| EPS (diluted) | $0.98 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $88.2M | $57.2M | ||
| Q3 25 | $89.3M | $56.3M | ||
| Q2 25 | $87.5M | $52.6M | ||
| Q1 25 | $84.3M | $50.0M | ||
| Q4 24 | $85.3M | $53.2M | ||
| Q3 24 | $80.6M | $47.7M | ||
| Q2 24 | $79.2M | $50.5M | ||
| Q1 24 | $79.9M | $47.5M |
| Q4 25 | $23.7M | $-141.2M | ||
| Q3 25 | $22.5M | $-22.6M | ||
| Q2 25 | $23.4M | $-27.2M | ||
| Q1 25 | $22.2M | $-29.5M | ||
| Q4 24 | $19.2M | $-4.9M | ||
| Q3 24 | $19.5M | $-5.3M | ||
| Q2 24 | $19.7M | $-4.5M | ||
| Q1 24 | $20.5M | $-4.1M |
| Q4 25 | 34.0% | -70.5% | ||
| Q3 25 | 32.2% | -55.6% | ||
| Q2 25 | 34.4% | -73.2% | ||
| Q1 25 | 33.4% | -82.0% | ||
| Q4 24 | 29.7% | -19.3% | ||
| Q3 24 | 31.5% | -23.1% | ||
| Q2 24 | 33.7% | -20.1% | ||
| Q1 24 | 33.7% | -19.5% |
| Q4 25 | 26.8% | -246.8% | ||
| Q3 25 | 25.2% | -40.1% | ||
| Q2 25 | 26.8% | -51.7% | ||
| Q1 25 | 26.3% | -58.9% | ||
| Q4 24 | 22.5% | -9.2% | ||
| Q3 24 | 24.2% | -11.2% | ||
| Q2 24 | 24.9% | -9.0% | ||
| Q1 24 | 25.6% | -8.7% |
| Q4 25 | $0.98 | $-2.40 | ||
| Q3 25 | $0.94 | $-0.38 | ||
| Q2 25 | $0.98 | $-0.46 | ||
| Q1 25 | $0.93 | $-0.50 | ||
| Q4 24 | $0.81 | $-0.09 | ||
| Q3 24 | $0.81 | $-0.09 | ||
| Q2 24 | $0.82 | $-0.08 | ||
| Q1 24 | $0.86 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.9M |
| Total DebtLower is stronger | $354.5M | — |
| Stockholders' EquityBook value | $958.7M | $327.2M |
| Total Assets | $8.0B | $488.9M |
| Debt / EquityLower = less leverage | 0.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.9M | ||
| Q3 25 | — | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | — | $102.3M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $103.0M | ||
| Q1 24 | — | $125.2M |
| Q4 25 | $354.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $958.7M | $327.2M | ||
| Q3 25 | $932.2M | $466.0M | ||
| Q2 25 | $894.1M | $486.3M | ||
| Q1 25 | $870.9M | $511.4M | ||
| Q4 24 | $846.4M | $538.5M | ||
| Q3 24 | $858.5M | $541.2M | ||
| Q2 24 | $813.6M | $542.5M | ||
| Q1 24 | $798.0M | $544.0M |
| Q4 25 | $8.0B | $488.9M | ||
| Q3 25 | $7.8B | $601.1M | ||
| Q2 25 | $7.7B | $624.7M | ||
| Q1 25 | $7.6B | $631.9M | ||
| Q4 24 | $7.5B | $656.2M | ||
| Q3 24 | $7.6B | $645.1M | ||
| Q2 24 | $7.6B | $651.4M | ||
| Q1 24 | $7.7B | $652.7M |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.9M | $-29.4M |
| Free Cash FlowOCF − Capex | $124.0M | $-29.5M |
| FCF MarginFCF / Revenue | 140.6% | -51.6% |
| Capex IntensityCapex / Revenue | 7.8% | 0.2% |
| Cash ConversionOCF / Net Profit | 5.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | $207.9M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.9M | $-29.4M | ||
| Q3 25 | $33.0M | $-31.6M | ||
| Q2 25 | $7.7M | $-15.3M | ||
| Q1 25 | $47.9M | $-33.1M | ||
| Q4 24 | $124.4M | $-1.8M | ||
| Q3 24 | $33.1M | $-14.6M | ||
| Q2 24 | $24.0M | $-6.9M | ||
| Q1 24 | $29.0M | $7.6M |
| Q4 25 | $124.0M | $-29.5M | ||
| Q3 25 | $31.9M | $-31.8M | ||
| Q2 25 | $6.0M | $-15.6M | ||
| Q1 25 | $46.0M | $-33.6M | ||
| Q4 24 | $119.5M | $-2.0M | ||
| Q3 24 | $32.0M | $-14.7M | ||
| Q2 24 | $22.9M | $-7.0M | ||
| Q1 24 | $27.6M | $7.6M |
| Q4 25 | 140.6% | -51.6% | ||
| Q3 25 | 35.8% | -56.5% | ||
| Q2 25 | 6.8% | -29.6% | ||
| Q1 25 | 54.5% | -67.1% | ||
| Q4 24 | 140.0% | -3.8% | ||
| Q3 24 | 39.7% | -30.9% | ||
| Q2 24 | 28.9% | -13.9% | ||
| Q1 24 | 34.5% | 15.9% |
| Q4 25 | 7.8% | 0.2% | ||
| Q3 25 | 1.2% | 0.3% | ||
| Q2 25 | 2.0% | 0.6% | ||
| Q1 25 | 2.3% | 0.9% | ||
| Q4 24 | 5.8% | 0.4% | ||
| Q3 24 | 1.4% | 0.3% | ||
| Q2 24 | 1.4% | 0.2% | ||
| Q1 24 | 1.9% | 0.0% |
| Q4 25 | 5.53× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 2.16× | — | ||
| Q4 24 | 6.49× | — | ||
| Q3 24 | 1.70× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 1.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMBH
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
